ACCP collaborates with ASHP on Oncology Pharmacy activities.

• Series Overview
• Program Content
• Faculty
• Target Audience and Learning Objectives
• Continuing Pharmacy Education Credit
• BCOP Specialty Recertification Credit
• Technical Requirements
• Commercial Support
• Fees

2020 ACCP/ASHP BCOP Clinical Sessions have been approved by the Board of Pharmacy Specialties for recertification of Board Certified Oncology Pharmacy Specialists (BCOPs). The sessions are jointly sponsored by ACCP and the American Society of Health-System Pharmacists.

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants’ skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

Release date: December 16, 2020
BCOP credit expiration date: December 14, 2021
ACPE credit expiration date: October 28, 2023

The 2020 ACCP/ASHP BCOP Clinical Sessions are offered in two presentations. The first presentation is focused on oncology supportive care and the second presentation is focused on pain management in the oncology patient.

	Eva E. Coulson, Pharm.D., BCPS Pharmacy Pain Management Clinical Specialist Kaweah Delta Health Care District Visalia, California
	Christopher T. Elder, Pharm.D., BCOP Assistant Professor of Pharmacy Practice Lloyd L. Gregory School of Pharmacy Palm Beach Atlantic University West Palm Beach, Florida
	Nicole Eye, Pharm.D. Acute Pain Clinical Pharmacist Avera McKennan Hospital and University Health Center Sioux Falls, South Dakota
	Kirollos S. Hanna, Pharm.D., BCOP, BCPS Oncology Pharmacy Manager M Health Fairview Assistant Professor of Pharmacy Mayo Clinic College of Medicine Minneapolis, Minnesota
	Lee A. Kral, Pharm.D., BCPS Pain Management Clinical Pharmacy Specialist and Adjunct Assistant Professor Department of Anesthesia Center for Pain Medicine The University of Iowa Hospitals and Clinics Iowa City, Iowa

Target Audience: Clinical Pharmacists and BCOPs providing care to patients with cancer.

Learning Objectives:

Oncology Supportive Care: Navigating the Expanding Realm of Oral Small Molecule Inhibitors
At the conclusion of this application-based educational activity, participants should be able to do the following:

1. Describe the mechanism of action of tyrosine kinase inhibitors and multi-kinase inhibitors and how the differences contribute to their respective toxicity profile.
2. Evaluate the current monitoring parameters for FDA-approved small molecule inhibitors and recognize areas of ambiguity.
3. Design a customized treatment plan for a patient presenting with a small molecule inhibitor-related adverse event.
4. Recommend effective approaches for monitoring patients on small molecule inhibitors to improve patient outcomes.

Why Am I Only Offering Oncology Pain Patients Opioids? Is There Anything Else, Anything at All?
At the conclusion of this application-based educational activity, participants should be able to do the following:

1. Identify oncology patients which would benefit the most from additional non-opioid pain management options.
2. For a given patient, describe the possible mechanism of pain and choose an appropriate therapeutic option based on available evidence for management.
3. Given a patient case, identify which IT pump therapy would be most beneficial to the patient’s oncologic pain management regimen.
4. For a given patient, evaluate whether he/she would have an indication for interventional therapies.

The American Society of Health-System Pharmacists and American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

BCOP Clinical Session
Oncology Supportive Care: Navigating the Expanding Realm of Oral Small Molecule Inhibitors
Activity Number: 0217-9999-20-123-H01-P
Contact Hours: 2.00
Activity Type: Application-Based Activity

BCOP Clinical Session
Why Am I Only Offering Oncology Pain Patients Opioids? Is There Anything Else, Anything at All?
Activity Number: 0217-9999-20-124-H08-P
Contact Hours: 2.00
Activity Type: Application-Based Activity

Methods and CE Requirements

ACPE Continuing Pharmacy Education Credit
To be eligible to earn continuing pharmacy education credit, participants must purchase the product, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by October 28, 2023. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

To be eligible to earn BCOP recertification credit, participants must purchase the recertification version of this course, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by December 14, 2021. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

The passing point to earn BCOP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCOP posttest deadline that meets this passing point will earn BCOP recertification credits. These credits will be assigned as of the date of test submission. For statements of recertification credit, visit www.bpsweb.org.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Questions regarding the number of hours required for BCOP recertification should be directed to BPS at (202) 946-5026 or www.bpsweb.org.

• Internet browser
• Adobe Reader (available free)

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.